SP

Seetharaman Pandurengan Janardanan

Director Director DIN 03628909
DIN 03628909 First appointment Apr 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2012
Shareholding value •••• Premium profile

About Seetharaman Pandurengan Janardanan

Data last updated:

Seetharaman Pandurengan Janardanan was a Director at Be-Line Pharmaceuticals Private Limited (2012–2021) and Managing Director at Mithun Kausik Chits Private Limited (2023–2025). The companies operate in Pharma.

DIN 03628909
Primary Designation Director
Industry Pharma
First Appointment 05 Apr 2012

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Apr 20121994₹2.16 Cr (FY 2025)Active
Mithun Kausik Chits Private Limited U64990TN2023PTC160312
Managing Director10 May 20232023₹6.1 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Be-Line Pharmaceuticals Private Limited
Mithun Kausik Chits Private Limited
Premium access

Shareholding and investment profile for Seetharaman Pandurengan Janardanan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seetharaman Pandurengan Janardanan

Seetharaman Pandurengan Janardanan was first appointed on 05 Apr 2012 as Director at Be-Line Pharmaceuticals Private Limited. The most recent appointment on record is 10 May 2023 at Mithun Kausik Chits Private Limited.

Seetharaman Pandurengan Janardanan held 2 earlier board appointments: Be-Line Pharmaceuticals Private Limited (Director, 05 Apr 2012 to 15 Mar 2021); Mithun Kausik Chits Private Limited (Managing Director, 10 May 2023 to 13 Feb 2025).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available